Annual Drug Patent Expirations for DILAUDID
Dilaudid is a drug marketed by Fresenius Kabi Usa and Rhodes Pharms and is included in three NDAs. It is available from three suppliers. There are three patents protecting this drug and four Paragraph IV challenges.
Drug patent litigation for DILAUDID.
This drug has thirty-five patent family members in fifteen countries.
The generic ingredient in DILAUDID is hydromorphone hydrochloride. Three suppliers are listed for this compound. Additional details are available on the hydromorphone hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
